Telix Files Form 20-F Registration Statement for Nasdaq ADS
October 18, 2024 | 04:32
Telix Pharmaceuticals Limited announces that it has publicly filed a Form 20-F registration statement with the United States Securities and Exchange Commission relating to a proposed listing of American Depository Shares, representing the Company's ordinary shares, on the Nasdaq Stock Market.
Mobile Version